Fueling Biotech Breakthroughs: Investment Strategies and Startup Success in US Pharma R&D

Tuesday, June 2, 2026 2:35 PM to 3:15 PM · 40 min. (America/New_York)
Main Stage
Track 2 - R&D Excellence – Biologics
Bio-ManufacturingInvestmentManufacturingMarket InsightsR&D

Information

This session will explore the current funding environment for biotech startups and emerging companies while examining CDMO services supporting R&D studies and early-stage development. Gain investor perspectives on biotech valuations and market opportunities, and discover success factors for biotech fundraising in challenging market conditions. Learn about innovation ecosystem support for emerging biotechnology companies and understand strategic considerations for biotech-pharma partnerships to navigate the complex landscape of biotech financing and collaboration.
Pfizer Inc.910At Pfizer CentreOne we help maximize your product's potential and reach patients faster. As a reliable extension of your network, we provide premium commercial manufacturing for your oral solids, sterile injectables and biologic drug products. You gain direct access to Pfizer's network of global sites, and benefit from our cutting-edge process optimization, scalable commercial manufacturing solutions and secure supply chains. Powered by Pfizer, we spent decades earning an uncompromising reputation for quality that we'll dedicate to the lightspeed delivery of your project.

Registered attendees

AG
Alan Goodloe
SalesW.S. Tyler
Anand Menon
Anand Menon
Head - Business Development – East CoastPI Health Sciences
Dan Smithey, PhD
Dan Smithey, PhD
President & CEOSeran Bioscience

Log in

See all the content and easy-to-use features by logging in or registering!